Category: Science Explained
KSM-66 is one of the best-known branded ashwagandha extracts: made from the root only and standardised to a defined withanolide level. Here is what those terms mean, how it compares with the root-and-leaf Sensoril extract, and the honest evidence picture.
Category: Science Decoded | Reading time: ~8 min | Level: Intermediate
Shop for ashwagandha and you quickly hit a wall of brand names: KSM-66, Sensoril, and others, each presented as the serious choice. It is tempting to reach for whichever has the biggest withanolide percentage, on the reasonable assumption that more is better. That assumption is where most people go wrong, because these are not the same extract at different strengths. They are genuinely different preparations, made from different parts of the plant.
KSM-66 is the one you will meet most often, and it is worth understanding on its own terms before comparing it to anything. This is a plain account of what KSM-66 actually is, what withanolides are, how it differs from the root-and-leaf Sensoril extract, and, just as importantly, the honest state of the evidence and the cautions that come with ashwagandha whatever brand is on the label.
KSM-66 is a branded, standardised extract of ashwagandha, Withania somnifera. Two features define it. First, it is made from the root of the plant only. Second, it is standardised to a defined level of withanolides, the marker compounds used to describe ashwagandha's concentration [1]. Being a named, standardised extract means each batch is controlled to a set specification, so the product is reproducible and can be matched to the preparation used in clinical studies.
The idea in one sentence: KSM-66 is a specific, quality-controlled root extract of ashwagandha, not a generic powder, and that specificity is its main advantage [1]. Because several of the better-known ashwagandha trials used KSM-66, choosing it is one way to take a preparation that has actually been studied, rather than an unknown quantity.
Withanolides are a group of naturally occurring compounds found in ashwagandha, and they serve as its marker constituents [1]. When a label says standardised to a percentage of withanolides, that percentage refers to these compounds.
They are associated with ashwagandha's proposed effects, and the leading mechanistic explanation involves the herb calming the body's stress axis, with withanolides implicated [1]. But two honest qualifications matter. Ashwagandha contains many constituents, and its activity is not attributed to withanolides alone. And the withanolide percentage is a consistency measure, not a potency guarantee: a higher figure means more concentrated by that one marker, not necessarily a bigger effect. This is the same logic that applies to any standardised extract, and it is the key to reading the KSM-66 versus Sensoril comparison sensibly.
Here is the comparison that trips people up. KSM-66 and Sensoril are both branded ashwagandha extracts, but they are made differently. KSM-66 uses the root only and is standardised to a defined withanolide level. Sensoril uses both root and leaf and is typically standardised to a higher withanolide percentage.
The instinct is to read Sensoril's higher percentage as superior. That instinct is wrong, or at least unproven. The higher figure reflects Sensoril's root-and-leaf sourcing, which naturally yields a different, more concentrated withanolide profile, not a demonstrated advantage in effect. The two are different preparations with different compound profiles, studied in different ways and often at different doses. Neither root-only nor root-and-leaf is inherently correct. Choosing between them is not about which number is bigger; it is about which extract has evidence for the outcome you care about, at a dose you can match. For stress specifically, KSM-66 is the extract behind several of the well-known trials, which is a practical reason to prefer it for that goal.
It is easy to let a branded extract and a precise percentage create an impression of certainty. The honest evidence picture is more measured. Ashwagandha has moderate evidence for stress-related effects, concentrated in chronically stressed adults, with trials, several using KSM-66, reporting reductions in a stress hormone and in self-reported stress over roughly two months [1][3].
Moderate is the right word. It means the evidence is real but limited in quantity and consistency, not settled, and independent reviews describe some outcomes such as anxiety as unclear [1]. So the fair summary is that KSM-66 is a well-studied ashwagandha preparation with reasonable support for stress in the right population, working over weeks rather than overnight. The branded extract makes the dose reproducible and matchable to the studies; it does not upgrade the grade. A consistent dose of a moderately evidenced herb is still a moderately evidenced herb.
If you are going to trial ashwagandha for stress, using a well-characterised standardised extract at a studied dose gives you the best chance of replicating what the trials found, and KSM-66 is a reasonable, well-matched choice for that goal. Prefer a product that names its extract and states a withanolide level and a dose in the studied range over an unnamed, unstandardised ashwagandha, even at a higher price, because the unnamed one is a bigger unknown.
Do not choose on the withanolide percentage alone. A higher number is a sourcing artefact, not a proven benefit, so match the extract and dose to the evidence rather than chasing the biggest figure. And set realistic expectations: the stress and cortisol effects in trials emerge over roughly 60 days, so a fair trial is measured in weeks, not days.
A branded, standardised extract does not soften ashwagandha's safety profile, and that profile carries real cautions. There is a recognised signal of liver injury, uncommon but formally assessed as a likely cause, usually appearing weeks into use and mostly mild, so ashwagandha should be avoided in existing liver disease and stopped if signs of liver problems appear [2].
It is contraindicated in pregnancy and not used while breastfeeding, and it is generally avoided in thyroid and autoimmune conditions and before surgery [1][2]. It interacts with several medicine classes, including thyroid, sedative, immune-suppressing, diabetes and blood pressure medicines [1]. KSM-66 shares all of these.
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
We treat KSM-66 the way we treat all standardisation: as a genuine way to get a consistent, trial-comparable dose, and not as a promise of a stronger effect than the evidence supports. The value is reproducibility, and the grade for ashwagandha stays honest at moderate.
Our ashwagandha stress tonic is described in structure and function terms and grounded in the evidence for well-characterised ashwagandha preparations, with its cautions stated plainly rather than buried. For a full head-to-head, our comparison of KSM-66, Sensoril and Shoden goes deeper, and our piece on how long ashwagandha takes to work sets the timescale expectation. Remy can help you match an extract and dose to your goal.
1. National Center for Complementary and Integrative Health (2023). Ashwagandha. Government evidence synthesis describing moderate stress evidence, unclear anxiety evidence, standardisation to withanolides, and safety cautions including thyroid, autoimmune and pregnancy. 2. National Institutes of Health, LiverTox (2023). Ashwagandha. NCBI Bookshelf NBK548536. Hepatotoxicity assessment giving a likelihood score of a likely cause of clinically apparent liver injury, usually mild, with advice to avoid in advanced liver disease. 3. Chandrasekhar K, Kapoor J, Anishetty S (2012). A prospective, randomized double-blind, placebo-controlled study of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety, 64 adults. Indian Journal of Psychological Medicine. Trial using a root extract reporting reductions in a stress hormone and self-reported stress over 60 days.
KSM-66 is a branded, standardised extract of ashwagandha (Withania somnifera). Two things define it: it is made from the root of the plant only, and it is standardised to a defined level of withanolides, the marker compounds used to describe ashwagandha's concentration. Being a named, standardised extract means its batches are controlled to a set specification, which makes it reproducible and lets it be matched to the preparation used in clinical studies. It is one of the most widely used ashwagandha extracts in supplements and in research.
Withanolides are a group of naturally occurring compounds found in ashwagandha and used as its marker constituents. When an ashwagandha extract says standardised to a percentage of withanolides, that percentage refers to these compounds. They are associated with the herb's proposed effects, though ashwagandha contains many constituents and the activity is not attributed to withanolides alone. The withanolide percentage is a quality and consistency measure, not a guarantee of a stronger effect, and different extracts use different percentages depending on the plant part and process.
They are two different branded ashwagandha extracts. KSM-66 uses the root only and is standardised to a defined withanolide level. Sensoril uses both root and leaf and is typically standardised to a higher withanolide percentage. A higher percentage is not automatically better: the plant part matters, the compound profile differs, and the two have been studied in different ways and often at different doses. Choosing between them is less about which number is bigger and more about which preparation matches the evidence and goal you care about.
Not necessarily, and this is a common misunderstanding. A higher withanolide percentage means the extract is more concentrated by that one measure, but it does not straightforwardly translate into a stronger or better effect. Extracts using different plant parts and processes reach different percentages, and the whole compound profile, not a single marker, shapes how a preparation behaves. Sensoril's higher percentage reflects its root-and-leaf sourcing, not a proven superiority. The more useful question is which extract and dose have been tested for the outcome you are interested in.
The root-only approach reflects a particular sourcing and standardisation choice, and root has a long history of traditional use in ashwagandha preparations. Using the root only produces a different compound profile from a root-and-leaf extract, which is one reason KSM-66 and Sensoril are standardised to different withanolide levels. Neither root-only nor root-and-leaf is inherently correct; they are different preparations. What matters for a buyer is that the extract they choose matches one with evidence for their goal, and root-only KSM-66 has been used in several well-known stress trials.
Ashwagandha has moderate evidence for stress-related effects in chronically stressed adults, and KSM-66 is the extract used in several of those studies, including work reporting reductions in a stress hormone and in self-reported stress over roughly two months. Moderate means the evidence is real but limited in quantity and consistency, not settled. So it is fair to say KSM-66 is a well-studied ashwagandha preparation with reasonable support for stress in the right population, provided expectations are set at moderate evidence and a timescale of weeks, not an overnight effect.
KSM-66 carries the same safety profile as ashwagandha, and ashwagandha has real cautions. There is a recognised signal of liver injury, uncommon but assessed as a likely cause in formal review, so it should be avoided in existing liver disease and stopped if signs of liver problems appear. It is contraindicated in pregnancy and not used while breastfeeding, and it is generally avoided in thyroid and autoimmune conditions and before surgery. It also interacts with several medicine classes. Being a branded standardised extract does not remove these cautions.
It can matter quite a bit. Much of ashwagandha's better evidence used specific standardised extracts at specific doses, so a product that does not name its extract or state a withanolide level leaves you unable to tell whether it matches anything that was studied. Naming a well-characterised extract such as KSM-66, with its standardised level and a dose in the studied range, is a sign the product can be matched to evidence. An unnamed, unstandardised ashwagandha is a bigger unknown, even if it is cheaper.
Look at which extract has evidence for the outcome and at what dose, rather than at which has the higher withanolide number. KSM-66 has been used in several stress and cortisol trials in chronically stressed adults, which makes it a reasonable, well-matched choice for that goal. Sensoril has its own studies and a different profile. Because they are different preparations, the honest approach is to match the extract and dose to the studied use, and to discuss it with a clinician if you take medication or have a relevant condition.
The branded extract does not raise the evidence grade, but it does let you take a consistent, trial-comparable dose, which is the practical value of standardisation. If you are going to trial ashwagandha for stress, using a well-studied standardised extract at a studied dose gives you the best chance of replicating what the trials found. That is worth something. What it is not is a guarantee, and it does not change ashwagandha's moderate grade or its cautions, both of which still apply.